Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein

Abstract

Protein phosphatase 1 (PP1) plays important roles in many different aspects of cellular activities including cell cycle control. One important function of PP1 is to activate the retinoblastoma protein pRB. Here we show that pRB is one of PP1's downstream targets during apoptosis. When HL-60 cells synchronized at the G1/S boundary were treated with pro-apoptotic cytosine arabinoside (araC), PP1α protein increased twofold and PP1 activity about 30% within 1 h. This was followed by pRB dephosphorylation, pRB cleavage by caspases, DNA fragmentation, the appearance of cells with <2n DNA content and finally, dying and dead cells. In vitro, pRB was protected from caspase-3 digestion by prior Cdk-mediated phosphorylation, whereas PP1α converted phospho-pRB into an efficient substrate for caspase-3. Introduction of active PP1α into HL-60 cells by electroporation was sufficient to induce characteristics of apoptosis. Similarly, araC-resistant cells, normally unable to die in response to araC, initiated apoptosis when electroporated with active PP1α. This was also accompanied by pRB cleavage. In contrast, introduction of inhibitor-2 delayed the onset of araC-induced apoptosis, whereas concomitant introduction of PP1α and inhibitor-2 completely prevented PP1α-induced apoptosis. These results suggest that dephosphorylation of key proteins by PP1α may be crucial for the initiation of apoptosis and further support the concept of PP1 serving as a potential target for anti-cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Alberts AS, Thorburn AM, Shenolikar S, Mumby MC, Feramisco JR . 1993 Proc. Natl. Acad. Sci. USA 90: 388–392

  • Axton JM, Dómbradi V, Cohen PTW, Glover DM . 1990 Cell 63: 33–46

  • Ayllón V, Martínez-A C, García A, Cayla X, Rebollo A . 2000 EMBO J. 19: 2237–2246

  • Baxter GD, Lavin MF . 1992 J. Immunol. 148: 1949–1954

  • Berndt N . 1995 Adv. Prot. Phosphatases 9: 63–86

  • Berndt N . 1999 Front. Biosci. 4: d22–d42

  • Berndt N . 2000 Emerg. Ther. Targets 4: 581–608

  • Berndt N, Dohadwala M, Liu CWY . 1997 Curr. Biol. 7: 375–386

  • Berry DE, Lu Y, Schmidt B, Fallon PG, O'Connell C, Hu S-X, Xu H-J, Blanck G . 1996 Oncogene 12: 1809–1819

  • Bøe R, Gjertsen BT, Vintermyr OK, Houge G, Lanotte M, Døskeland SO . 1991 Exp. Cell Res. 195: 237–246

  • Booher RN, Beach D . 1989 Cell 57: 1009–1016

  • Bradford MM . 1976 Anal. Biochem. 72: 248–254

  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge EJ, Frisch S, Reed JC . 1998 Science 282: 1318–1321

  • Chen W, Otterson GA, Lipkowitz S, Khleif SN, Coxon AB, Kaye FJ . 1997 Oncogene 14: 1243–1248

  • Cheng AY, Dean NM, Honkanen RE . 2000 J. Biol. Chem. 275: 1846–1854

  • Clarke AR, Maandag ER, Van Roon M, Van der Lugt NMT, Van der Valk M, Hooper ML, Berns A, Te Riele H . 1992 Nature 359: 328–330

  • Damer CK, Partridge J, Pearson WR, Haystead TAJ . 1998 J. Biol. Chem. 273: 24396–24405

  • Dohadwala M, Berndt N . 1998 Protein Phosphatase Protocols Vol 93. Ludlow JW (ed) Humana Press: Totowa, NJ pp 191–199

    Book  Google Scholar 

  • Dohadwala M, Da Cruz e Silva EF, Hall FL, Williams RT, Carbonaro-Hall DA, Nairn AC, Greengard P, Berndt N . 1994 Proc. Natl. Acad. Sci. USA 91: 6408–6412

  • Dou QP, An B, Will PL . 1995 Proc. Natl. Acad. Sci. USA 92: 9019–9023

  • Downward J . 1998 Curr. Opin. Cell Biol. 10: 262–267

  • Dunigan DD, Madlener JC . 1995 Virology 207: 460–466

  • Durfee T, Becherer K, Chen P-L, Yeh S-H, Yang Y, Kilburn AE, Lee W-H, Elledge SJ . 1993 Genes Dev. 7: 555–569

  • Fan G, Ma X, Kren BT, Steer CJ . 1996 Oncogene 12: 1909–1919

  • Fernandez A, Brautigan DL, Lamb NJC . 1992 J. Cell Biol. 116: 1421–1430

  • Green DR . 1998 Cell 94: 695–698

  • Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung Y-KT, Israel MA . 1995 EMBO J. 14: 461–472

  • Hotz MA, Gong J, Traganos F, Darzynkiewicz Z . 1994 Cytometry 15: 237–244

  • Inomata M, Saijo N, Kawashima K, Kaneko A, Fujiwara Y, Kunikane H, Tanaka Y . 1995 J. Cancer Res. Clin. Oncol. 121: 729–738

  • Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA . 1992 Nature 359: 295–300

  • Jänicke RU, Walker PA, Lin XY, Porter AG . 1996 EMBO J. 15: 6969–6978

  • Knudsen KE, Weber E, Arden KC, Cavenee WK, Feramisco JR, Knudsen ES . 1999 Oncogene 18: 5239–5245

  • Kwon Y-G, Lee S-Y, Choi Y, Greengard P, Nairn AC . 1997 Proc. Natl. Acad. Sci. USA 94: 2168–2173

  • Laemmli UK . 1970 Nature 227: 680–685

  • Lazebnik YA, Kaufmann SH, Desnoyer S, Poirier GG, Earnshaw WC . 1994 Nature 371: 346–347

  • Lee EYHP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A . 1992 Nature 359: 288–294

  • Liu CWY, Wang R-H, Dohadwala M, Schönthal AH, Villa-Moruzzi E, Berndt N . 1999 J. Biol. Chem. 274: 29470–29475

  • Ludlow JW, Glendening CL, Livingston DM, DeCaprio JA . 1993 Mol. Cell. Biol. 13: 367–372

  • Martin-Aragon S, Mukherjee SK, Taylor BJ, Ivy SP, Fu CH, Ardi VC, Avramis VI . 2000 Anticancer Res. 20: 139–150

  • Martin SJ, Green DR . 1995 Cell 82: 349–352

  • Mihara K, Cao X-R, Yen A, Chandler S, Driscoll B, Murphree AL, T'Ang A, Fung Y-KT . 1989 Science 246: 1300–1303

  • Morana SJ, Wolf CM, Li J, Reynolds JE, Brown MK, Eastman A . 1996 J. Biol. Chem. 271: 18263–18271

  • Morimoto Y, Ohba T, Kobayashi S, Haneji T . 1997 Exp. Cell Res. 230: 181–186

  • Ohkura H, Kinoshita N, Miyatani S, Toda T, Yanagida M . 1989 Cell 57: 997–1007

  • Puntoni F, Villa-Moruzzi E . 1999 Biochem. Biophys. Res. Commun. 266: 279–283

  • Schönthal AH, Feramisco JR . 1993 Oncogene 8: 433–441

  • Shibasaki F, McKeon F . 1995 J. Cell Biol. 131: 735–743

  • Spector DL, Goldman RD, Leinwand LA . 1998 Cells–A Laboratory Manual Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY

    Google Scholar 

  • Takemura M, Kitagawa T, Izuta S, Wasa J, Takai A, Akiyama T, Yoshida S . 1997 Oncogene 15: 2483–2492

  • Tan X, Wang JYJ . 1998 Trends Cell Biol. 8: 116–120

  • Taylor BK, Stoops TD, Everett AD . 2000 Am. J. Physiol. 278: L1062–L1070

  • Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF, Reed JC . 1999 Science 284: 339–343

  • Yamano H, Ishii K, Yanagida M . 1994 EMBO J. 13: 5310–5318

  • Yi H-K, Fujimura Y, Ouchida M, Prasad DDK, Rao VN, Reddy SP . 1997 Oncogene 14: 1259–1268

  • Zheng B, Woo CF, Kuo JF . 1991 J. Biol. Chem. 266: 10031–10034

Download references

Acknowledgements

This work was supported in part by NIH grant CA54167 (to N Berndt). We wish to thank Balwant S Khatra, Charles J Sherr, David O Morgan, and Emma Villa-Moruzzi for their kind sharing of vectors and antibodies.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norbert Berndt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, RH., Liu, C., Avramis, V. et al. Protein phosphatase 1α-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein. Oncogene 20, 6111–6122 (2001). https://doi.org/10.1038/sj.onc.1204829

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204829

Keywords

This article is cited by

Search

Quick links